HLA-DRB1 and myeloid sarcoma: GWAS conducted on samples collected from thousands of MS patients and matched controls have identified over 200 genetic variants that elevate the risk of developing MS, with the most significant association being linked to the HLA-DRB1*1501 haplotype (32).